Nita, M E.(2012). Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system. Revista da Associação Médica Brasileira, 58(3), 294-301. doi:10.1016/s0104-4230(12)70198-7

Nita, Marcelo Eidi. "Cost-effectiveness and Budget Impact of Saxagliptine As Additional Therapy to Metformin for the Treatment of Diabetes Mellitus Type 2 in the Brazilian Private Health System". Revista Da Associação Médica Brasileira, 58.3 ( 2012 ): 294-301.